kinases which act as receptors for various growth facSrc family tyrosine kinases participate in the regula-tors and directly modulate substrate proteins by phostion of cell adhesion, cell growth and differentiation. phorylation through their catalytic intracellular doHere, we examine for the first time the potential role main (10). A second group of tyrosine kinases is located of Src for growth regulation of human pancreatic car-within the cytosol and acts as intermediate intracellucinoma cells. By immunohistochemical analysis, Src lar signal transducing proteins. Representatives of this was overexpressed in 13/13 pancreatic carcinoma tis-latter category are the Src family tyrosine kinases, sue but not in 6 normal pancreatic tissue specimen. which are enzymes with high structural similarity cou- other tissues so far (11). In fibroblasts, kinase-activated regulated through protein expression or through expression of Csk. The Src-specific tyrosine kinase inhib-Src-mutants are able to act as transforming oncogene, itor herbimycin A decreased cell growth in a dose-de-indicating the potential of Src for growth regulation pendent manner. We suggest that Src family kinases (12). In addition, infection of rat colon with retroviral participate in growth regulation of pancreatic cancer v-src induces dysplasia, and cotransfection with v-myc
induces carcinoma (13) . Based in part on this evidence, it has been speculated, that upregulation of the Src kinase is important for growth and transformation of intestinal epithelial cells (14) . The potential role of Src Knowledge of pancreatic cancer growth control is still in pancreatic cancer has not been examined. limited although many molecular changes have been Therefore, the purpose of this study was to determine reported which partly explain the aggressive nature of whether the tyrosine kinase Src might play a role in this tumor. These changes include loss of function of pancreatic tumor growth regulation. We now report, the tumor suppressor genes p53, DCC and DPC4, and that Src is overexpressed in human pancreatic carciactivating mutations of the proto-oncogene K-ras in at noma tissue as compared to normal pancreas. In addileast 70% of pancreatic tumors (1) (2) (3) (4) (5) . In addition, most tion, Src is activated in many cultured pancreatic carciof pancreatic cancers examined overexpress a number noma cells and cell growth is inhibited by herbimycin of tyrosine kinase growth factor receptors (6) (7) (8) . In anal-A, a Src kinase inhibitor, demonstrating the potential ogy to colon cancer or to breast cancer, it has been role of Src in regulation of pancreatic cancer cell prolifspeculated that some of these changes contribute to eration. rapid tumor growth, invasion or metastasis (9) .
Reversible phosphorylation of signal transducing MATERIAL AND METHODS proteins on tyrosine residues is a well recognized mechanism of cellular growth control. Tyrosine phosphoryla- mal pancreatic tissue samples were taken from 2 previously healthy by semi dry blotting. Membranes were blocked over night at room temperature in blocking buffer (10 mM Tris-HCl, pH 7.2, 150 mM multi organ donors in which no recipient for pancreatic transplantation was present at the time of explantation or from normal tissue sodium chloride, containing 2% bovine serum albumin and 0.1% Tween 20). After three washes for 10 min with 10 mM Tris-HCl, adjacent to the tumor (nÅ4). The studies were approved by the human ethics comittees of the Universities of Ulm, Germany, and Bern, pH 7.2, 150 mM sodium chloride, 0.2% Tween 20, membranes were incubated with clone 327 (1:1000) or with anti-Csk monoclonal antiSwitzerland. Short term cultivated human pancreatic cells, IMIM-PC-2, MS40-II, Sk-PC-2, and Hs766t cells were a gift of F.X.Real body (1:500, Transduction Laboratories, Lexington, KY) in blocking buffer. After three washing steps, horse radish peroxidase-coupled (Barcelona, Spain) (15) . PC-2, PC-3 cells were a gift of H. P. Elsä sser (Marburg, Germany). The human pancreatic carcinoma cell lines secondary antibody was added for one hour in blocking buffer. Antibodies were visualized after three additional washing steps using PaTu 8988s, PaTu 8988t and PaTu 8902 as well as the colon carcinoma cell line Colo 320 were from the 'Deutsche Sammlung fü r Mik-the ECL technique (Amersham, Buckinghamshire, England). roorganismen' (Braunschweig, Germany). The cell lines HPAF and Growth inhibition assays. Cells were plated in 96-well plates at AsPC 1 were from the American Type Culture Collection (Rockville, a density of 10,000 cells per well. After culture in standard medium MD). DanG, Capan-1, Capan-2, and the colon carcinoma cell line for 24 hours, herbimycin A was added as indicated. Control cells CaCo 2 were from the 'Deutsches Krebsforschungszentrum' (Heidel-were incubated with the appropriate concentrations of the carrier berg, Germany), and MIA Paca 2 and PANC-1 cells were from the DMSO. After 72 hours, cell number was estimated using the tetrazoEuropean Collection of Animal Cell Cultures (Salisbury, U.K.). Cells lium salt (MTT) assay (17) . Briefly, cells were incubated for 150 min were maintained under standard culture conditions in Dulbecco's in phosphate buffered saline containing 5 mg/ml MTT. After three modified eagle medium with high glucose and with 10% fetal calf washes in phosphate-buffered saline, the precipitated formazan was serum.
solubilized over night in 50% dimethylformamide containing 1% acetic acid, 1% hydrochloric acid, and 10% sodium dodecylsulfate. The Immunohistochemistry. Paraffin-embedded tissue sections (3) (4) absorption was measured at 570 nm and results were calculated mm) of human pancreatic tumor tissue and normal pancreas were relative to control cells which had been grown without inhibitor or deparaffinized and endogenous peroxidase activity was quenched uscarrier substance. For comparison, cell numbers were counted in ing 0.2% hydrogen peroxide in methanol. After rehydration, unspeseveral experiments and did yield similar results. cific binding was blocked with 1% bovine serum albumine. Polyclonal sheep Src antiserum (1:100, Affiniti, Exeter, UK) in phosphate-buffered saline containing 0.5% bovine serum albumine was added for RESULTS tissue specimen and in normal tissue of patient # 8. As 1% NP40, 1 mM sodium orthovanadate, 10 mg/ml aprotinin, 10 mg/ illustrated in Fig. 1 , all of the examined tumors did ml leupeptin, 0.5 mg/ml pepstatin A, 5 mM sodium fluoride, 1 mM phenylmethylsulfonyl fluoride and 10 mg/ml soybean trypsin inhibi-show strong cytoplasmic staining of more than 10 % of tor. Lysates were cleared by centrifugation at 13.000 1 g for 3 min. the tumor cells (Table 1) man organ grafts which develop a ductal phenotype sample buffer and proteins were resolved by gel electrophoresis in 8.75 % sodium dodecylsulfate polyacrylamide gels. The gels were after various time periods and two colon carcinoma cell stained with Coomassie brilliant blue to ensure that equal amounts lines known to express the activated Src kinase were of enolase were present, and labeled proteins were detected autora-used as controls (15; 18) . diographically on KODAK X-OMAT AR Films. Under these condiSrc protein expression was detected in 14 of the 17 tions, the amount of kinase activity measured was linearly related to the amount of protein extract used for immunoprecipitation.
tumor cell lines tested, and kinase activity was elevated in 12 of them (Fig. 2) . Kinase protein was undeWestern blotting. Lysates were separated in 8.75 % sodium dodetectable in the normal pancreatic tissue extracts, and cylsulfate polyacrylamide gels. Separated proteins were transferred to PVDF Membranes (Immobilon P, Sigma, Deisenhofen, Germany) a minor amount was expressed only in one of the three short term cultures of epithelial pancreatic cells. Sig-ation is demonstrated in Fig. 3 . Exposure of cells to herbimycin A decreased cell numbers with similar efficacy in nificant kinase activity could be detected in none of them. Kinase activity and protein expression were reg-all four cell lines tested. The effect of growth inhibition was significant after 2 days of incubation and reached ulated in a parallel fashion in both colon cancer cell lines as well as in PaTu 8988s and t, PC-2, MIA Paca-56% { 3.5% for PaTu 8988s cells, 60% { 5.6% for PaTu 8988t cells, 79% { 1.4% for PC 2 cells, and 76% { 0.7 % 2, PANC-1, HPAF and in Hs766t cells, whereas in the remaining 10 cell lines kinase activity was independent for PC 3 cells after three days of exposure to the drug.
The potency of growth inhibition was dependent on the from protein levels. Src protein expression and kinase activities were quantified densitometrically to calcu-level of activity of the Src kinase. In PaTu 8988s, PC 2, and PC 3 cells, which do express relevant kinase activity, late correlation coefficients. Src activity levels did not correlate with protein expression (correlation coeffi-growth was inhibited with IC 50 's of 60 ng/ml, 20 ng/ml, and 50 ng/ml, respectively. In contrast, growth of the cell cient Å 0.2). The C-terminal Src kinase Csk is a major regulatory protein for Src activity. Therefore, expres-line PaTu 8988t which has barely detectable levels of Src kinase was inhibited at halfmaximal concentrations of sion of Csk was determined in Western blots (Fig. 2C) and quantified densitometrically. We did not find sig-above 350 ng/ml and maximal inhibition was not reached at 2,000 ng/ml. After incubation with concentrations of nificant correlation of Csk expression and relative Src activity (correlation coefficient Å 00.2).
up to 2000 ng/ml of the inhibitor for four days, more than 95% of the cells were viable and did exclude trypan blue. The effects of herbimycin A were reversible, i.e. cells could Inhibition of Cell Growth by Herbimycin A be trypsinized and subcultured after removal of the inhibitor and addition of standard culture medium for 24 Herbimycin A inhibits Src kinase activity in vitro as well as in vivo. The effect of herbimycin A on cell prolifer-hours. Paraffin-embedded exocrine pancreatic carcinoma tissue sections were stained immunohistochemically for Src. The percentage of Srcpositive tumor cells is indicated as / (10-20% positive cells), // (21-40%), /// (41-60%), and //// (61-80%). Tumors were graded according to standard pathological criteria with well differentiated tumor graded 1, and undifferentiated tumors graded 3. TNM stage was established from surgical specimen using UICC criteria. Controls were normal pancreatic tissue specimen (n Å 2) or normal pancreatic tissue adjacent to tumor tissue of patients 8, 9, 12 and 13.
the folded kinase is thought to be unable to couple to DISCUSSION downstream signaling proteins. Repression of Src famMembers of the Src-kinase family participate in the ily kinase activity is critically dependent on phosphorycontrol of a variety of cellular functions, including the lation by Csk. Deletion of Csk results in markedly inresponse to various polypeptide growth factors or the creased Src kinase activity (20) , whereas overexregulation of the cellular cytoskeleton. Activated Src pression inhibits Src kinase activity (21) . In the present stimulates cell growth and may act as transforming study, Csk expression and relative Src activity did not oncogene (11). Our results indicate, that the tyrosine correlate. A role of Csk for the regulation of Src in kinase Src is overexpressed in malignant pancreatic pancreatic carcinoma therefore seems unlikely and the tissue as compared to adjacent normal tissue. In addi-mechanisms of Src activation remain to be determined. tion, expression of Src is increased in neoplastic cell Other regulating factors which could account for the lines as compared to primary cultures of normal human upregulation of Src acitivity are overexpression of repancreatic cells with ductular differentiation and the ceptor tyrosine kinases like HER-2 or the epidermal kinase is activated in neoplastic cells only. Therefore, growth factor receptor which are able to activate Src pancreatic tumor cells seem to possess a specific mech-in mammary tumor cells or in fibroblasts (22; 23) , or anism of kinase regulation.
the activation of Ras which induces accumulation and Src kinase activity may be regulated either by chang-increased activity of Src in transformed fibroblasts (24). ing protein expression or by specific regulation of kiTo investigate the role of Src for pancreatic tumor nase activity (11). A parallel increase or decrease in cell growth control, we examined the effects of the tyroSrc expression and activity was observed only in 6/ sine kinase inhibitor herbimycin A, which is known to 17 cell lines. Overall, levels of kinase activity did not inhibit Src and Src-related kinases in vivo and in vitro correlate with the abundance of the kinase protein and by binding to their SH2 domains (25) . Growth inhibiactivation of Src in pancreatic carcinoma cells therefore tion by herbimycin A correlated with the level of Src was not regulated by protein expression. Regulation of kinase activation. Cell lines with elevated kinase activSrc has been extensively studied and a mechanism of ity were inhibited with higher potency than the cell inactivation by phosphorylation and by phosphoryla-line PaTu 8988t, which expresses low levels of Src and tion-dependent folding of the protein was suggested barely detectable kinase activities. Similar observa- (19) . According to this model, phosphorylation of Src tions have been made in colonic tumor cell lines, where on Tyr-527 by Csk or Csk-like kinases results in intra-herbimycin A decreased growth and Src kinase activimolecular binding of this residue to the SH2 domain. ties by over 40% at concentrations of 125 ng/ml, but Folding is further stabilized by interaction of the SH3 was ineffective in cell lines derived from normal colonic tissue (26). Taken together with the observation that domain with an unidentified region of the protein and 
